| 期 |
标题 |
文件 |
| 卷 97, 编号 10 (2025): Issues of endocrinology |
The perspectives in obesity and type 2 diabetes therapy: the present and future of incretin therapy |
(Rus)
|
|
Shestakova M., Bashlykova R.
|
| 卷 97, 编号 9 (2025): Issues of cardiology |
Cardiology and cardiac surgery – a symbiosis of successful treatment of heart failure |
(Rus)
|
|
Uskach T., Amanatova V., Ardus D., Sapelnikov O., Imaev T., Tereshchenko S.
|
| 卷 97, 编号 8 (2025): Treatment issues |
Current status and prospects of using potassium-competitive acid blockers in gastroenterology |
(Rus)
|
|
Maev I., Andreev D., Zaborovsky A., Fomenko A.
|
| 卷 97, 编号 7 (2025) |
Clinical portrait and features of antihypertensive therapy in comorbid patients with arterial hypertension and chronic obstructive pulmonary disease according to the national hypertension registry |
(Rus)
|
|
Aksenova A., Serov I., Belova O., Rachkova S., Chazova I.
|
| 卷 97, 编号 6 (2025): Issues of nephrology |
Modern approaches to the chronic glomerulonephritis classification |
(Rus)
|
|
Bobkova I., Lysenko L., Kamyshova E., Moiseev S.
|
| 卷 97, 编号 5 (2025): Issues of rheumatology |
Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century |
(Rus)
|
|
Nasonov E.
|
| 卷 97, 编号 4 (2025): Вопросы диагностики |
Current approaches to risk stratification in choosing the optimal strategy for examination and early treatment of patients with pulmonary embolism |
(Rus)
|
|
Komarov A.
|
| 卷 97, 编号 3 (2025): Пульмонология |
Pulmonary health: From neonatology to gerontology |
(Rus)
|
|
Chuchalin A.
|
| 卷 97, 编号 2 (2025): Вопросы гастроэнтерологии |
Radiation-induced intestinal injury |
(Rus)
|
|
Parfenov A., Indejkina L., Sabelnikova E., Leontiev A., Makarova A.
|
| 卷 97, 编号 1 (2025): Поликлинические проблемы и организация медицинской помощи |
Emergency measures in the diagnosis and treatment of chronic forms of ischemic heart disease |
(Rus)
|
|
Boytsov S., Provatorov S., Shestova I., Nikulina N.
|
| 卷 96, 编号 12 (2024): VARIO (РАЗНОЕ) |
Modern strategies for the gastric cancer prevention |
(Rus)
|
|
Bordin D., Nikolskaya K., Chebotareva M., Khatkov I.
|
| 卷 96, 编号 11 (2024): Инфекционные заболевания |
Coagulase-negative staphylococci as a significant fact of generalization of infection in persons with a burdened comorbid background |
(Rus)
|
|
Maleev V., Lazareva E., Ponezheva Z., Kuznetsova Y.
|
| 卷 96, 编号 10 (2024): Вопросы эндокринологии |
Autoimmune and iodine deficiency diseases of the thyroid gland as the "tip of the iceberg" of multiple organ pathology |
(Rus)
|
|
Troshina E.
|
| 卷 96, 编号 9 (2024): Кардиология |
Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022) |
(Rus)
|
|
Aksenova A., Oschepkova E., Chazova I.
|
| 卷 96, 编号 8 (2024): Вопросы лечения |
Cytomegalovirus infection in gastroenterology |
(Rus)
|
|
Maev I., Velikolug K.
|
| 卷 96, 编号 7 (2024): VARIO |
Diagnosis and management of patients with pheochromocytoma/paraganglioma: Consensus of experts of the Russian Medical Society for Arterial Hypertension and the Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors |
(Rus)
|
|
Blinova N., Ilovayskaya I., Chikhladze N., Lugovskaya A., Britvin T., Gurevich L., Nefedova L., Shikina V., Chazova I.
|
| 卷 96, 编号 6 (2024): Нефрология |
Kidney involvement in rare hereditary diseases |
(Rus)
|
|
Moiseev S., Shilov E.
|
| 卷 96, 编号 4 (2024) |
Expert Center for cardiac amyloidosis: reality and perspectives |
(Rus)
|
|
Nasonova S., Zhirov I., Shoshina A., Osmolovskaya Y., Ansheles A., Tchaikovskaya O., Dobrovolskaya S., Sergienko V., Saidova M., Tereshchenko S., Boytsov S.
|
| 卷 96, 编号 3 (2024) |
Prevention and treatment of COVID-19 based on post-genomic pharmacological analysis: Systematic computer analysis of 290,000 scientific articles on COVID-19 |
(Rus)
|
|
Torshin I., Gromova O., Chuchalin A.
|
| 卷 96, 编号 2 (2024) |
The value of increased intestinal permeability in the pathogenesis of internal diseases |
(Rus)
|
|
Parfenov A.
|
| 卷 96, 编号 1 (2024) |
Possibilities for improving hospital and remote forecasts for unstable angina |
(Rus)
|
|
Boytsov S., Provatorov S.
|
| 卷 95, 编号 11 (2023) |
Predictors of thromboembolic complications in patients with severe SARS-CoV-2 coronavirus infection |
(Rus)
|
|
Podzolkov V., Volchkova E., Tarzimanova A., Bragina A., Ivannikov A., Bykova E., Shvedov I., Oganesyan K., Isaeva A.
|
| 卷 95, 编号 10 (2023) |
Diabetes mellitus type 2: National Russian guidelines vs real clinical practice |
(Rus)
|
|
Shestakova M., Vikulova O., Zheleznyakova A., Dedov I., Mokrysheva N.
|
| 卷 95, 编号 9 (2023) |
Creation of registers as one of the mechanisms for improving medical care for patients with chronic heart failure. Problem state |
(Rus)
|
|
Reitblat O., Airapetian A., Lazareva N., Mezhonov E., Sorokin E., Prints I., Blankova Z., Svirida O., Ageev F., Zhirov I., Tereshchenko S., Boytsov S.
|
| 卷 95, 编号 8 (2023) |
Drug-induced liver injury: diagnosis of exclusion |
(Rus)
|
|
Maev I., Polunina T.
|
| 卷 95, 编号 7 (2023) |
Positron emission tomography in cardiological practice |
(Rus)
|
|
Sergienko V., Ansheles A.
|
| 卷 95, 编号 6 (2023) |
State-of-the-art paradigm of corticosteroid therapy for immune-mediated inflammatory kidney diseases |
(Rus)
|
|
Bulanov N., Bobkova I., Moiseev S.
|
| 卷 95, 编号 5 (2023) |
Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future |
(Rus)
|
|
Nasonov E., Reshetnyak T., Solovyev S., Popkova T.
|
| 卷 95, 编号 4 (2023) |
Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension |
(Rus)
|
|
Shariya A., Martynyuk T., Shariya M., Ustyuzhanin D.
|
| 卷 95, 编号 3 (2023) |
Respiratory disorders of post-COVID-19 syndrome |
(Rus)
|
|
Leshchenko I., Esaulova N., Glushkova T., Skornyakov S.
|
| 卷 95, 编号 2 (2023) |
Abdominal pain |
(Rus)
|
|
Parfenov A.
|
| 卷 95, 编号 1 (2023) |
Possibilities of dispensary observation in reducing mortality from coronary heart disease |
(Rus)
|
|
Boytsov S., Provatorov S.
|
| 卷 94, 编号 12 (2022) |
Anemia of chronic diseases: current state of the problem and perspectives |
(Rus)
|
|
Mironova O., Panferov A.
|
| 卷 94, 编号 11 (2022) |
Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19 |
(Rus)
|
|
Stanevich O., Bakin E., Korshunova A., Gudkova A., Afanasev A., Shlyk I., Lioznov D., Polushin Y., Kulikov A.
|
| 卷 94, 编号 10 (2022) |
Obesity and diabetes – are they always together? |
(Rus)
|
|
Shestakova M., Shestakova E., Sklyanik I., Stafeev I.
|
| 卷 94, 编号 9 (2022) |
Acute decompensation of heart failure: state of the problem |
(Rus)
|
|
Zhirov I., Nasonova S., Tereshchenko S.
|
| 卷 94, 编号 8 (2022) |
Prospects for personalized Helicobacter pylori eradication therapy. Pro et contra |
(Rus)
|
|
Simanenkov V., Alekseenko S.
|
| 卷 94, 编号 7 (2022) |
Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics |
(Rus)
|
|
Valieva Z., Martynyuk T.
|
| 卷 94, 编号 6 (2022) |
Lupus nephritis in the XXI century |
(Rus)
|
|
Bobkova I., Moiseev S., Lysenko L., Kamyshova E.
|
| 卷 94, 编号 5 (2022) |
Janus kinase inhibitors in immunoinflammatory rheumatic diseases |
(Rus)
|
|
Nasonov E.
|
| 卷 94, 编号 4 (2022) |
Molecular cardiology: from decoding the genetic nature and mechanisms of the diseases development to the introduction into the clinic |
(Rus)
|
|
Zateyshchikov D., Favorova O., Chumakova O.
|
| 卷 94, 编号 3 (2022) |
Dyspnea: neurobiological and clinical aspects |
(Rus)
|
|
Chuchalin A.
|
| 卷 94, 编号 2 (2022) |
Food intolerances and the small intestine |
(Rus)
|
|
Parfenov A.
|
| 卷 94, 编号 1 (2022) |
Chronic heart failure: evolution of etiology, prevalence and mortality over the past 20 years |
(Rus)
|
|
Boytsov S.
|
| 卷 93, 编号 12 (2021) |
Low adherence to treatment is a weak link in the problems of ulcerative colitis |
(Rus)
|
|
Parfenov A., Knyazev O., Babayan A., Kagramanova A.
|
| 卷 93, 编号 11 (2021) |
Peculiarities of blood coagulation disorders in patients with COVID-19 |
(Rus)
|
|
Evtugina N., Sannikova S., Peshkova A., Safiullina S., Andrianova I., Tarasova G., Khabirova A., Rumyantsev A., Ataullakhanov F., Litvinov R.
|
| 卷 93, 编号 10 (2021) |
Modern problems of hyper- and hypoparathyroidism |
(Rus)
|
|
Mokrysheva N., Eremkina A., Kovaleva E., Krupinova J., Vikulova O.
|
| 卷 93, 编号 9 (2021) |
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future |
(Rus)
|
|
Martynyuk T., Chazova I.
|
| 卷 93, 编号 8 (2021) |
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management |
(Rus)
|
|
Bakulin I., Skalinskaya M., Maev I., Skazyvaeva E., Zhuravleva M., Gaikovaya L., Bakulina N., Ermakov A., Alekseenko E., Ivanova K., Solovev M.
|
| 卷 93, 编号 7 (2021) |
Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects |
(Rus)
|
|
Parovichnikova E., Lukianova I., Troitskaya V., Drokov M., Kuzmina L., Sokolov A., Kokhno A., Fidarova Z., Galtseva I., Davydova Y., Kashlakova A., Gribanova E., Zvonkov E., Sysoeva E., Dvirnyk V., Obukhova T., Sudarikov A., Sidorova Y., Kulikov S., Chabaeva Y., Savchenko V.
|
| 卷 93, 编号 6 (2021) |
Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs |
(Rus)
|
|
Kamyshova E., Bobkova I., Sekacheva M.
|
| 卷 93, 编号 5 (2021) |
2019 Coronavirus disease (COVID-19): contribution of rheumatology |
(Rus)
|
|
Nasonov E.
|
| 卷 93, 编号 4 (2021) |
Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow |
(Rus)
|
|
Sergienko V., Ansheles A.
|
| 卷 93, 编号 3 (2021) |
COVID-19 and human security |
(Rus)
|
|
Chuchalin A.
|
| 卷 93, 编号 2 (2021) |
Enteropathy with impaired membrane digestion and the prospects for cytoprotective therapy |
(Rus)
|
|
Parfenov A., Akhmadullina O., Belostotsky N., Sabelnikova E., Novikov A., Bykova S., Dbar S.
|
| 卷 93, 编号 1 (2021) |
Modern content and improvement of high cardiovascular risk strategy in reducing mortality from cardiovascular diseases |
(Rus)
|
|
Boytsov S., Drapkina O.
|
| 卷 92, 编号 11 (2020) |
Hepatitis C awareness among therapists and general practitioners. Survey results |
(Rus)
|
|
Sineglazova A., Sineglazova A.
|
| 卷 92, 编号 10 (2020) |
Iodine deficiency disorders as a non-infectious epidemic: a look at the problem at the tome of COVID-19 pandemic |
(Rus)
|
|
Mel’nichenko G., Troshina E., Gerasimov G.
|
| 卷 92, 编号 9 (2020) |
COVID-19 and cardiovascular diseases |
(Rus)
|
|
Chazova I., Mironova O.
|
| 卷 92, 编号 8 (2020) |
Novel coronavirus infection COVID-19: extrapulmonary manifestations |
(Rus)
|
|
Maev I., Shpektor A., Vasilyeva E., Manchurov V., Andreev D.
|
| 卷 92, 编号 7 (2020) |
Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007–2016) |
(Rus)
|
|
Mikhaylova E., Fidarova Z., Abramova A., Luchkin A., Troitskaya V., Dvirnyk V., Galtseva I., Kliasova G., Kovrigina A., Kulikov S., Chabaeva Y., Parovichnikova E., Savchenko V., Obukhova T.
|
| 卷 92, 编号 5 (2020) |
Anniversary of the honored scientist professor Sergey Nikolaevich Tereshchenko |
|
|
Therapeutic archive B.
|
| 卷 92, 编号 3 (2020) |
Evaluation of the relationship between the parameters of peripheral skeletal and respiratory muscles in patients with chronic obstructive pulmonary disease |
(Rus)
|
|
Suleymanova A., Baranova I.
|
| 卷 92, 编号 3 (2020) |
Fatal severe community-acquired pneumonia: risk factors, clinical characteristics and medical errors of hospital patients |
(Rus)
|
|
Postnikova L., Klimkin P., Boldina M., Gudim A., Kubysheva N.
|
| 卷 92, 编号 3 (2020) |
Evaluation of the effectiveness of ARVI treatment regimen including etiotropic (enisamium iodide) and symptomatic treatment |
(Rus)
|
|
Lioznov D., Karnaukhova E., Zubkova T., Shakhlanskaya E.
|
| 卷 92, 编号 3 (2020) |
Changes in gut microbiota with bronchial asthma |
(Rus)
|
|
Zolnikova O., Potskhverashvili N., Kudryavtseva A., Krasnov G., Guvatova Z., Truhmanov A., Kokina N., Ivashkin V.
|
| 卷 92, 编号 3 (2020) |
The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169) |
(Rus)
|
|
Mariandyshev A., Khokhlov A., Smerdin S., Shcherbakova V., Igumnova O., Ozerova I., Bolgarina A., Nikitina N.
|
| 卷 92, 编号 3 (2020) |
UNESCO: bioethical initiatives in 2019 |
(Rus)
|
|
Chuchalin A.
|
| 卷 92, 编号 3 (2020) |
Assessment of the respiratory muscles strength at patients with chronic obstructive pulmonary disease with various forms of comorbidity |
(Rus)
|
|
Kurpatov I., Geltser B., Kinyaikin M.
|
| 卷 92, 编号 3 (2020) |
Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity |
(Rus)
|
|
Ovsyannikov E., Avdeev S., Budnevsky A.
|
| 卷 92, 编号 3 (2020) |
Comparative analysis of the strength of the respiratory muscles in community-acquired pneumonia with different severity of endogenous intoxication |
(Rus)
|
|
Geltser B., Dej A., Titorenko I., Kotelnikov V.
|
| 卷 92, 编号 3 (2020) |
The risk of bronchial asthma exacerbations among smokers with asthma-chronic obstructive pulmonary disease overlap after inpatient treatment |
(Rus)
|
|
Gnoevykh V., Smirnova A., Shorokhova Y., Gening T., Abakumova T.
|
| 卷 92, 编号 3 (2020) |
Clinical and diagnostical value of 24-hour arterial stiffness monitoring in patients with bronchial asthma |
(Rus)
|
|
Karoli N., Zarmanbetova O., Rebrov A.
|
| 卷 92, 编号 2 (2020) |
Vedolizumab in patients with inflammatory bowel diseases of in real clinical practice |
(Rus)
|
|
Shapina M., Nanaeva B.
|
| 卷 92, 编号 2 (2020) |
Chronic pancreatitis with IBS-like syndrome: approach to therapy |
(Rus)
|
|
Kozlova I., Bykova A., Osadchuk M.
|
| 卷 92, 编号 2 (2020) |
Hyperammonaemia in patients with chronic obstructive pulmonary disease and obesity: association mechanisms, detection rate and correction |
(Rus)
|
|
Kozhevnikova S., Tribuntseva L., Budnevsky A.
|
| 卷 92, 编号 2 (2020) |
Systemic manifestations of inflammatory bowel diseases |
(Rus)
|
|
Parfenov A., Kagramanova A., Knyazev O.
|
| 卷 92, 编号 2 (2020) |
Clinical implications of chronic mesenteric ischemia in elderly and senile patients |
(Rus)
|
|
Dolgushina A., Kuznecova A., Seljanina A., Genkel V., Vasilenko A.
|
| 卷 92, 编号 2 (2020) |
European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow |
(Rus)
|
|
Bordin D., Voynovan I., Embutnieks Y., Nyssen O., Megraud F., O`Morain C., Perez-Gisbert J.
|
| 卷 92, 编号 2 (2020) |
Esophageal disorders in patients with irritable bowel syndrome |
(Rus)
|
|
Morozova Y., Pogromov A., Mnatsakanyan M., Tashchyan O., Kolosova K.
|
| 卷 92, 编号 2 (2020) |
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C |
(Rus)
|
|
Maev I., Kuznetsova E., Andreev D., Dicheva D.
|
| 卷 92, 编号 2 (2020) |
Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease |
(Rus)
|
|
Vakhrushev Y., Suchkova E., Lukashevich A.
|
| 卷 92, 编号 2 (2020) |
The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus |
(Rus)
|
|
Nabatchikova E., Abdurakhmanov D., Nikulkina E., Rozina T., Tanaschuk E., Nikiforova N., Adonyeva V., Moiseev S.
|
| 卷 92, 编号 2 (2020) |
Сlinical, immunological and morphological features in different types of autoimmune hepatitis |
(Rus)
|
|
Sandler Y., Saliev K., Backih S., Khomeriki S., Khaymenova T., Dorofeev A., Sbikina E., Vinnitskaya E.
|
| 卷 92, 编号 2 (2020) |
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease |
(Rus)
|
|
Cherkashchenko N., Livzan M., Krolevets T.
|
| 卷 92, 编号 1 (2020) |
Assessment of external risk factors of hepatocellular cancer development and markers of genetic predisposition to its development in the ethnic group of yakut - men |
(Rus)
|
|
Yushchuk N., Sleptsova S., Malov S., Bilukina I., Semenov S., Stepanenko L., Ogarkov O., Savilov E., Malov I.
|
| 卷 92, 编号 1 (2020) |
The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study |
(Rus)
|
|
Bideeva T., Maev I., Kucheryavyy Y., Andreev D., Shah Y., Lobanova E., Zaborovskiy A., Levchenko A.
|
| 卷 92, 编号 1 (2020) |
The possibilities of using levosimendan in medical preparation to Coronary Artery Bypass Grafting in coronary artery disease patients with low left ventricular ejection fraction |
(Rus)
|
|
Gazizova V., Vlasova E., Dzybinskaya E., Gramovich V., Stukalova O., Shiryaev A., Akchurin R.
|
| 卷 92, 编号 1 (2020) |
Assessment of the clinical efficacy of telemonitoring and distant counseling in patients with uncontrolled hypertension |
(Rus)
|
|
Ionov M., Zhukova O., Zvartau N., Kurapeev D., Yudina Y., Konradi A.
|
| 卷 92, 编号 1 (2020) |
Frailty syndrome. What physicians and cardiologists need to know? |
(Rus)
|
|
Krivoshapova K., Vegner E., Barbarash O.
|
| 卷 92, 编号 1 (2020) |
Hypertension and insomnia |
(Rus)
|
|
Ostroumova T., Parfenov V., Ostroumova O., Kochetkov A.
|
| 卷 92, 编号 1 (2020) |
Etiology of severe community - acquired pneumonia in adults: results of the first Russian multicenter study |
(Rus)
|
|
Zakharenkov I., Rachina S., Dekhnich N., Kozlov R., Sinopalnikov A., Ivanchik N., Yatsyshina S., Elkina M., Archipenko M., Gordeeva S., Lebedeva M., Portnyagina U.
|
| 卷 92, 编号 1 (2020) |
The epidemiological situation as a factor determining the strategy for reducing mortality in the Russian Federation |
(Rus)
|
|
Boytsov S., Shalnova S., Deev A.
|
| 卷 92, 编号 1 (2020) |
Pancreatic diseases and inflammatory bowel diseases: a random or regular combination? |
(Rus)
|
|
Akhmedov V., Gaus O.
|
| 卷 92, 编号 1 (2020) |
The use of nonsteroidal anti - inflammatory drugs in polymorbid pathology |
(Rus)
|
|
Asfandiyarova N., Philippov E.
|
| 卷 92, 编号 1 (2020) |
Impact of endothelial dysfunction on the course of acute ST-elevation myocardial infarction and its correction by remote ischemic preconditioning |
(Rus)
|
|
Manchurov V., Lebedeva A., Ryazankina N., Vasilieva E., Shpektor A.
|
| 卷 92, 编号 1 (2020) |
Role of preoperative cardiology consultation in patients undergoing cancer surgery |
(Rus)
|
|
Sumin A., Starovojtova A., Scheglova A., Gorbunova E.
|
| 卷 92, 编号 1 (2020) |
The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy |
(Rus)
|
|
Avdeev S., Aisanov Z., Belevsky A., Beeh K., Vizel A., Zyryanov S., Ignatova G., Kostikas K., Leshchenko I., Ovcharenko S., Sinopal’nikov A., Titova O., Shmelev E.
|
| 卷 92, 编号 1 (2020) |
Psychosocial risk factors for cardiovascular disease: gender differences and 22-year dynamics among the population of Siberia (WHO MONICA-Psychosocial Program, HAPIEE) |
(Rus)
|
|
Gafarov V., Gagulin I., Gafarova A., Panov D., Krymov E., Gromova E.
|
| 卷 91, 编号 12 (2019) |
Left ventricular non - compaction: contemporary view of genetic background, clinical course, diagnostic and treatment |
(Rus)
|
|
Streltsova A., Gudkova A., Kostareva A.
|
| 卷 91, 编号 12 (2019) |
Psychosocial factors and coronary heart disease |
(Rus)
|
|
Kubareva M., Ibatov A.
|
| 卷 91, 编号 12 (2019) |
Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice |
(Rus)
|
|
Fomin V., Morosova T., Tsurko V.
|
| 卷 91, 编号 12 (2019) |
The effectiveness of target therapy in patients with severe allergic asthma |
(Rus)
|
|
Skorokhodkina O., Valeeva A., Luntsov A., Pozdnyak V.
|
| 卷 91, 编号 12 (2019) |
Peculiarities of heart risk in patients with non - alcoholic fatial liver disease |
(Rus)
|
|
Mosina L., Stolyarova V., Esina M., Titojkina Y., Korobkov D.
|
| 卷 91, 编号 12 (2019) |
Damage to periarticular soft tissues in real clinical practice: frequency, nature, effectiveness of non - steroidal anti - inflammatory drugs |
(Rus)
|
|
Karateev A., Lila A., Zagorodni N., Pogozheva E.
|
| 卷 91, 编号 12 (2019) |
Features of central hemodynamics in patients with community - acquired pneumonia depending on the course of the disease and cardiovascular comorbidity |
(Rus)
|
|
Titova O., Kuzubova N., Aleksandrov A., Perley V., Volchkova E., Baryshnikova K.
|
| 卷 91, 编号 12 (2019) |
Does the lack of left ventricular reverse remodeling always mean non - response to cardiac resynchronization therapy? |
(Rus)
|
|
Kuznetsov V., Soldatova A., Enina T., Krinochkin D., Dyachkov S.
|
| 卷 91, 编号 12 (2019) |
Heart - type fatty acid binding protein in prognosis of ischemic stroke at the hospital stage |
(Rus)
|
|
Lyang O., Kochetov A., Zhirova I., Novozhenova Y., Ivoylov O., Stakhovskaya L.
|
| 卷 91, 编号 12 (2019) |
Intravascular ultrasound with virtual histology in assessment of atherosclerotic plaque composition in patients with coronary artery disease and type 2 diabetes mellitus |
(Rus)
|
|
Zakharov A., Michurova M., Terekhin S., Kalashnikov V., Smirnova O., Shestakova M., Dedov I.
|
| 卷 91, 编号 12 (2019) |
Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development |
(Rus)
|
|
Vakhrushev Y., Suchkova E., Lukashevich A.
|
| 卷 91, 编号 12 (2019) |
Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma |
(Rus)
|
|
Kolbin A., Avdeev S., Zhuravleva M., Gomon Y., Balykina Y., Matveyev N., Proskurin M., Fedosenko S.
|
| 卷 91, 编号 12 (2019) |
Diseases of biliary tract in the context of association with oncological diseases of the digestive system |
(Rus)
|
|
Osadchuk M., Svistunov A., Mironova E., Vasil’eva I., Kireeva N.
|
| 卷 91, 编号 12 (2019) |
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults |
(Rus)
|
|
Shmalts A., Gorbachevsky S.
|
| 卷 91, 编号 12 (2019) |
The clinical status and treatment options for osteoarthritis in patients with frailty |
(Rus)
|
|
Naumov A., Khovasova N., Moroz V., Tkacheva O., Shavlovskaya O.
|
| 卷 91, 编号 12 (2019) |
Evolution of pathogenetic therapy of pulmonary arterial hypertension |
(Rus)
|
|
Chazova I., Yarovoy S., Danilov N.
|
| 卷 91, 编号 12 (2019) |
Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? |
(Rus)
|
|
Barbarash O., Kashtalap V.
|
| 卷 91, 编号 12 (2019) |
Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide |
(Rus)
|
|
Ushkalova E., Zyryanov S., Zatolochina K.
|
| 卷 91, 编号 12 (2019) |
Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features |
(Rus)
|
|
Kalmykova Z., Kononenko I., Mayorov A.
|
| 卷 91, 编号 12 (2019) |
Peripheral nervous system lesion in systemic vasculitis - issues of diagnosis and treatment |
(Rus)
|
|
Golovach I., Yehudina Y.
|
| 卷 91, 编号 11 (2019) |
Treatment of chronic viral hepatitis C with direct acting antiviral agent: review |
(Rus)
|
|
Malov V., Ubeeva E., Ubeeva I., Nikolaev S., Umbetova K.
|
| 卷 91, 编号 11 (2019) |
Immunological aspects of tuberculosis pathogenesis |
(Rus)
|
|
Gergert V., Averbakh M., Ergeshov A.
|
| 卷 91, 编号 11 (2019) |
Virus specific antibody - based remedies for the urgent prevention and treatment of Ebola virus disease |
(Rus)
|
|
Sizikova T., Lebedev V., Borisevich S.
|
| 卷 91, 编号 11 (2019) |
Review of current and future directions of antiviral therapy of influenza and acute respiratory viral infections in Russia |
(Rus)
|
|
Pshenichnaya N., Bulgakova V., Volchkova E., Kareva E., Selkova E., Gorodin V.
|
| 卷 91, 编号 11 (2019) |
Antiviral therapy of chronic hepatitis C: 30 years success story |
(Rus)
|
|
Abdurakhmanov D., Rozina T., Nikulkina E., Burnevich E., Tanashuk E., Severov M., Filatova A., Milovanova S., Karpov V., Moiseev S.
|
| 卷 91, 编号 11 (2019) |
Human babesiosis: clinical cases in the european part of the Russian Federation |
(Rus)
|
|
Tokmalaev A., Chentsov V., Malov V., Maleyev V., Kozhevnikova G., Polovinkina N., Golub V., Konnov V., Kharlamova T.
|
| 卷 91, 编号 11 (2019) |
Prinzmetal angina. Questions of pathogenesis, clinic, diagnosis and treatment |
(Rus)
|
|
Shklovskiy B., Prokhorchik A., Pyr’ev A., Baksheev V.
|
| 卷 91, 编号 11 (2019) |
Cardiovascular syphilis (current state of the problem and analysis of own observations) |
(Rus)
|
|
Krivosheev A., Nadeev A., Kuimov A., Travin M.
|
| 卷 91, 编号 11 (2019) |
Complexity of the therapy of P. falciparum - malaria in the Russian Federation |
(Rus)
|
|
Kovalenko A., Musatov V., Solovev A., Kapatcyna V.
|
| 卷 91, 编号 11 (2019) |
Helminths detection with video capsule endoscopy |
(Rus)
|
|
Akopova A., Mikcheeva O., Shcherbakov P., Parfenov A.
|
| 卷 91, 编号 11 (2019) |
The value of mucosal small intestine microbiota in digestion and absorption disorders in metabolic syndrome |
(Rus)
|
|
Lyapina M., Vakhrushev Y.
|
| 卷 91, 编号 11 (2019) |
Chronic hepatitis B and C as stigma: Is the problem relevant for Russian society? |
(Rus)
|
|
Baramzina S.
|
| 卷 91, 编号 11 (2019) |
Features of hemorrhagic fever with renal syndrome with diabetes mellitus |
(Rus)
|
|
Manakhov K., Kamenshchikova T., Tsarenko O., Borodina Z., Bagautdinova L., Sargsyan D., Malinin O., Dudarev M., Shklyaev A., Platonov A., Maleev V.
|
| 卷 91, 编号 11 (2019) |
Difficulties and mistakes in the diagnosis of abdominal tuberculosis in the practice of the general practitioner |
(Rus)
|
|
Savonenkova L., Ruzov V., Kolchin D., Arjamkina O., Skvortsov V., Bessonov A.
|
| 卷 91, 编号 11 (2019) |
Non - tuberculous mycobacteriosis of the lungs - diagnostic possibilities in the practice of the pulmonologist |
(Rus)
|
|
Vladimirova E., Shmelev E., Zaytseva A., Kovalevskaya M., Kasimtseva S., Amansakhedov R., Chernousova L., Ergeshov A., Shmeleva N.
|
| 卷 91, 编号 11 (2019) |
Listeriosis of the Central nervous system |
(Rus)
|
|
Nagibina M., Vengerov Y., Tishkevich O., Smirnova T., Baikova L., Svistunova T., Ryzhov G., Matosova S., Tsvetkova N., Sadykova V.
|
| 卷 91, 编号 11 (2019) |
Activity an enzyme 5`-nucleotidase in patients with chronic hepatitis C |
(Rus)
|
|
Galeeva N., Valeeva I.
|
| 卷 91, 编号 11 (2019) |
Features of dermatological pathology on the background of HIV-infection |
(Rus)
|
|
Tlish M., Naatyzh Z., Kuznetsova T., Gorodin V.
|
| 卷 91, 编号 11 (2019) |
A clinical case of visceral toxocariasis as a cause of eosinophilic polyserositis |
(Rus)
|
|
Shostak N., Klimenko A., Kotova D., Novikova A., Skripnichenko E.
|
| 卷 91, 编号 11 (2019) |
Analysis of the impact of vaccination of pneumococcal infection in patients with chronic obstructive pulmonary disease in combination with diabetes |
(Rus)
|
|
Ignatova G., Blinova E., Antonov V., Grebneva I.
|
| 卷 91, 编号 11 (2019) |
Risk Factors for diarrhea associated with Clostridium difficile in patients at a clinical hospital |
(Rus)
|
|
Yarushina Y., Kolotova G., Rudnov V., Bagin V.
|
| 卷 91, 编号 10 (2019) |
Relationship of the ovarian reserve with autoimmune thyroid diseases in the reproductive period |
(Rus)
|
|
Grigoryan O., Krasnovskaya N., Mikheev R., Yarovaia I., Andreeva E., Dedov I.
|
| 卷 91, 编号 10 (2019) |
Critical illness - related corticosteroid insufficiency in patients after cardiac surgery and cardiologic emergencies |
(Rus)
|
|
Komlev A., Kurilina E., Imaev T.
|
| 卷 91, 编号 10 (2019) |
Primary hyperaldosteronism: difficulties in diagnosis |
(Rus)
|
|
Shifman B., Platonova N., Molashenko N., Troshina E., Sitkin I., Belcevich D., Kovalevich L., Romanova N., Kolesnikova G.
|
| 卷 91, 编号 10 (2019) |
Abnormal values of trace elements and blood metals in patients with metabolic syndrome, depending on its components |
(Rus)
|
|
Podzolkov V., Korolyova T., Kudryavtseva M.
|
| 卷 91, 编号 10 (2019) |
Association of food patterns with different forms of small intestinal bacterial overgroth syndrome and treatment efficacy |
(Rus)
|
|
Pilipenko V., Isakov V., Morozov S., Vlasova A., Naydenova M.
|
| 卷 91, 编号 10 (2019) |
10-year risk of fractures (FRAX) in people with diabetes type 2 |
(Rus)
(Rus)
|
|
Mazurenko E., Malutina S., Shcherbakova L., Hrapova Y., Isaeva M., Rymar O.
|
| 卷 91, 编号 10 (2019) |
Problems of optimal nutrition of elderly and senile patients with comorbidities against obesity |
(Rus)
|
|
Starodubova A., Varaeva Y., Kosyura S., Livantsova E.
|
| 卷 91, 编号 10 (2019) |
The effect of bisphosphonate therapy on reducing the risk of cardiovascular complications associated with chronic heart failure, type 2 diabetes and osteoporosis in postmenopausal women |
(Rus)
|
|
Teplyakov A., Berezikova E., Shilov S., Popova A., Samsonova E., Yakovleva I., Molokov A., Grakova E., Kopeva K.
|
| 卷 91, 编号 10 (2019) |
Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus |
(Rus)
|
|
Genkel V., Salashenko A., Shamaeva T., Sumerkina V., Nikushkina K., Shaposhnik I.
|
| 卷 91, 编号 10 (2019) |
Lipid status and oxidative stress in menopausal women with obstructive apnea syndrome |
(Rus)
|
|
Kolesnikova L., Semenova N., Osipova E., Madaeva I.
|
| 1 - 150 的 3202 信息 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 > >>
|
